Skip to main content

Payton T. Thornton

(he/him/his)

Associate

[email protected]

+1.202.434.7435

Share:

Payton is an antitrust litigation associate, who practices in all aspects of antitrust, competition, and consumer protection law, including antitrust compliance counseling, Hart-Scott-Rodino (HSR) premerger notification filings and government merger review, and conduct investigations before the Federal Trade Commission, U.S. Department of Justice Antitrust Division, and state attorneys general. Payton provides strategic, business-centric advice to clients, primarily in the health care and technology industries. Payton also provides key guidance to clients engaging in strategic transactions throughout the HSR filing and review process, Second Requests, and merger litigation.

While at Mintz, Payton has represented several clients in the life sciences, health care, and technology industries in federal merger reviews before the FTC and DOJ Antitrust Division. Payton has subject matter expertise in the new filing requirements under the HSR Act and regularly counsels clients through diligence and the HSR filing process, as well as through Second Requests and merger reviews before the antitrust agencies. Payton also counsels clients through complex antitrust conduct investigations before the antitrust agencies and state attorneys general. During law school, Payton worked as an antitrust legal intern at Mintz, as an antitrust legal intern for a technology think tank, and as an in-house law clerk for a 501(c)(6) chamber of commerce. He also worked as a research assistant at the Global Antitrust Institute.

Payton earned his JD with a concentration in Antitrust Law. In law school, he served as editor-in-chief of the Journal of Law, Economics and Policy and was on the ABA Nationals Team of the Antonin Scalia Law School Moot Court Board.

viewpoints

The Federal Trade Commission (“FTC”), the Department of Justice Antitrust Division (“DOJ”), and the new proposed merger guidelines have all called out private equity transactions for particular scrutiny.
Read more

The FTC and DOJ jointly published draft merger guidelines reflecting the agencies’ current aggressive approach to merger enforcement. In an article, Mintz Antitrust attorneys discuss the draft guidelines’ move away from the consumer welfare standard, lower thresholds for deals presumed to be illegal, and other key changes, including a focus on the effect of industry roll-ups.

Read more

On Monday, the FTC lost its bid to preliminarily enjoin Microsoft’s acquisition of Activision, the maker of the popular video game, “Call of Duty.” 

Read more

The Federal Trade Commission, in coordination with the U.S. Department of Justice Antitrust Division, recently released a summary of the Agencies’ June 2022 joint workshop titled “The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.”

Read more

The Federal Trade Commission (“FTC”) announced Monday that it had reversed its in-house Administrative Law Judge’s (“ALJ”) Initial Decision dismissing a complaint brought by FTC staff against Illumina, Inc.’s acquisition of GRAIL, Inc.

Read more

On March 16, the U.S. Department of Justice Antitrust Division (“DOJ Antitrust Division”) announced that a federal grand jury returned an indictment charging a former health care staffing executive of fixing wages for nurses.

Read more

The Federal Trade Commission on Friday announced a Request for Information regarding “franchise agreements and franchisor business practices, including how franchisors may exert control over franchisees and their workers.”

Read more

In a closely watched private antitrust case, Saint Francis Hospital and Medical Center, Inc. (“St. Francis”) sued its rival, the Hartford Healthcare Corporation (“HHC”), and on February 13, 2023, the litigation survived a motion to dismiss.

Read more

Late last week, the U.S. Department of Justice Antitrust Division announced its withdrawal of a string of healthcare enforcement policy statements issued in 1993, 1996, and 2011.

Read more

Prior to the recent midterm elections, we wrote about five Senate Republicans who issued a warning letter to major U.S. law firms regarding the potential antitrust implications of Environmental, Social, and Governance (“ESG”) investing and activities. The letter advises that ESG activities may be viewed as “climate cartels” and present antitrust risk when firms engage in ESG group initiatives. With the midterm election results, those Senate Republicans will likely not be able to follow through on this line of investigation. However, House Republicans have taken up the issue, and they will have the ability to conduct antitrust scrutiny of ESG initiatives.

 
Read more
Read less

News & Press

News Thumbnail Mintz

An article written by Member Bruce Sokler and Associate Payton Thornton was recently published by Law360 about the Department of Justice’s Visa debit monopolization suit and how it might unfold. 

Read less

Publications

Read less

Payton is an antitrust litigation associate, who practices in all aspects of antitrust, competition, and consumer protection law, including antitrust compliance counseling, Hart-Scott-Rodino (HSR) premerger notification filings and government merger review, and conduct investigations before the Federal Trade Commission, U.S. Department of Justice Antitrust Division, and state attorneys general. Payton provides strategic, business-centric advice to clients, primarily in the health care and technology industries. Payton also provides key guidance to clients engaging in strategic transactions throughout the HSR filing and review process, Second Requests, and merger litigation.

Recognition & Awards

  • Washington DC Super Lawyers: Rising Star - Antitrust Litigation (2024-2025)

  • George Mason University Antonin Scalia Law School: Marketplace of Ideas Award (2022)

  • George Mason University Antonin Scalia Law School, LGBTQ Resources Center: Possibility Model Award (2022)

Read less

Payton is an antitrust litigation associate, who practices in all aspects of antitrust, competition, and consumer protection law, including antitrust compliance counseling, Hart-Scott-Rodino (HSR) premerger notification filings and government merger review, and conduct investigations before the Federal Trade Commission, U.S. Department of Justice Antitrust Division, and state attorneys general. Payton provides strategic, business-centric advice to clients, primarily in the health care and technology industries. Payton also provides key guidance to clients engaging in strategic transactions throughout the HSR filing and review process, Second Requests, and merger litigation.

Involvement

  • Young Lawyer Representative to The Antitrust Source, Antitrust Law Section, American Bar Association
  • Board of Directors, District of Columbia LGBTQ+ Bar Association, Social Chair
  • Member, American Health Law Association - Antitrust Practice Group
Read less